Behcet's syndrome pathophysiology and potential therapeutic targets

被引:51
|
作者
Emmi, Giacomo [1 ]
Silvestri, Elena [1 ,2 ,3 ]
Squatrito, Danilo [2 ,3 ]
D'Elios, Mario Milco [1 ,2 ,3 ]
Ciucciarelli, Lucia [1 ]
Prisco, Domenico [1 ,2 ,3 ]
Emmi, Lorenzo [2 ,3 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[2] AOU Careggi, SOD Patol Med, Ctr Autoimmune Syst Dis, Behcet Ctr, Florence, Italy
[3] AOU Careggi, Lupus Clin, Florence, Italy
关键词
Behcet syndrome pathophysiology; Behcet treatment; Biologic therapy; Anti-TNF-alpha; IL-1 blocking agents; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; V-GAMMA-9/V-DELTA-2; T-LYMPHOCYTES; FAMILIAL MEDITERRANEAN FEVER; INTERFERON ALPHA-2A; STREPTOCOCCUS-SANGUIS; DOUBLE-BLIND; TNF FAMILY; DISEASE; UVEITIS;
D O I
10.1007/s11739-013-1036-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behcet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behcet syndrome pathogenesis and their potential role as novel therapeutic targets.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [31] Therapeutic targets in bronchial asthma pathophysiology
    Galant, SP
    PEDIATRIC ASTHMA ALLERGY & IMMUNOLOGY, 1998, 12 (04) : 241 - 251
  • [32] Cholera: pathophysiology and emerging therapeutic targets
    Muanprasat, Chatchai
    Chatsudthipong, Varanuj
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (07) : 781 - 798
  • [33] Pathophysiology and therapeutic targets for ischemic stroke
    Levine, SR
    CLINICAL CARDIOLOGY, 2004, 27 (05) : 12 - 24
  • [34] Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets
    Largeau, Berenger
    Bergeron, Sandrine
    Auger, Florent
    Gandonniere, Charlotte Salmon
    Jonville-Bera, Annie-Pierre
    Ehrmann, Stephan
    Gautier, Sophie
    Bordet, Regis
    STROKE, 2024, 55 (02) : 484 - 493
  • [36] Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
    Kumar, Rahul
    Lee, Michael H.
    Mickael, Claudia
    Kassa, Biruk
    Pasha, Qadar
    Tuder, Rubin
    Graham, Brian
    ERJ OPEN RESEARCH, 2020, 6 (04) : 1 - 18
  • [37] Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets
    Paul, Jonathan A.
    Whittington, Robert A.
    Baldwin, Matthew R.
    ANESTHESIA AND ANALGESIA, 2020, 130 (06): : 1545 - 1555
  • [38] Genetic suppressors of Barth syndrome as potential targets for therapeutic intervention
    Malhotra, Ashim
    Edelman-Novemsky, Irit
    Xu, Yang
    Ma, Jinping
    Schlame, Michael
    Ren, Mindong
    MITOCHONDRION, 2010, 10 (02) : 207 - 208
  • [39] Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets
    Kim, Lenise J.
    Polotsky, Vsevolod Y.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 26
  • [40] Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
    Canto e Sousa, Julia
    Fauaze Santana, Ana Carolina
    Prado Magalhaes, Gabriela Jesus
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (08) : 501 - 511